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Abstract Overexpression of protein kinase C-K and protein
kinase C-N has been shown to modulate a number of biological
effects, including the cell growth and differentiation. We
hypothesized that heparin, a potent antimitogenic drug, could
affect the cell proliferation by inhibiting the expression of
specific protein kinase C genes. Heparin, markedly but not
completely, inhibited the serum-stimulated protein kinase C-K
and -N mRNA expression. Protein kinase C inhibition or down-
regulation significantly decreased the serum-induced protein
kinase C isoenzyme gene expression. Heparin failed to inhibit the
residual effect of serum that was resistant to the above-
mentioned treatments. Phorbol 12-myristate 13-acetate elicited
an increase of protein kinase C isoenzyme gene expression that
was completely prevented by protein kinase C inhibition or down-
regulation. Heparin dose-dependently counteracted and ulti-
mately abolished the increase in the protein kinase C isoenzyme
gene expression elicited by phorbol 12-myristate 13-acetate.
These results suggest that the inhibition of an autoregulatory role
wielded by protein kinase C on the protein kinase C-K and -N
gene expression might represent a possible mechanism by which
glycosaminoglycans modulate the cell growth.
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1. Introduction
Protein kinase C (PKC) is a multigene family of serine/
threonine kinases which plays a fundamental role in a variety
of cellular functions [1]. PKC isoenzymes are di¡erentially
expressed and respond di¡erently to physiological stimuli in
various tissues and cell types [2], supporting the view that
di¡erent PKC isoforms subserve distinct functional roles with-
in cells. It is now recognized that at least 10 di¡erent isoforms
that have been identi¢ed by molecular cloning may contribute
to the PKC activity [3^5]. Conventional PKCs (K, LI, LII and
Q) are Ca2-dependent phospholipid-activated enzymes [1,6].
Novel PKCs (N, O, R and a), lacking the C2 Ca2 binding
domain are Ca2-independent diacylglycerol (DAG)-activated
isoenzymes. Atypical PKCs (j and V/S), which are both Ca2-
and DAG-independent enzymes, have been found to be acti-
vated by phosphatidylserine and other lipid-derived mediators
[1,6,7]. In di¡erent cell types, including human endothelial
cells (HEC), vascular smooth muscle cells (VSMC) and ¢bro-
blasts, PKC plays a crucial role in the modulation of cell
growth and di¡erentiation, being implicated both in prolifer-
ative and anti-proliferative responses [8,9]. In addition, PKC
activation by phorbol esters induces migration, proliferation
[10] and tube formation in cultured endothelial cells [11], as
well as angiogenesis in vitro [12,13]. The crucial role of PKC
in transducing growth regulatory signals is also highlighted by
the ¢nding that the down-regulation of PKC-dependent path-
ways elicits growth inhibitory responses. In particular, glycos-
aminoglycan-mediated inhibition of cell proliferation [14^16]
and angiogenesis [17] has been associated, at least in part, to
the ability of heparin and heparan sulfate to counteract PKC-
mediated events [18^20]. In this regard, we have recently
shown that heparin markedly reduced both the serum- and
phorbol ester-stimulated DNA synthesis in HEC by eliciting
the down-regulation of the PKC-mediated ornithine decar-
boxylase gene expression (ODC) [21]. The elucidation of the
e¡ects induced by growth regulators on the expression of
selected PKC genes is now becoming an area of inquiry. In
the present study, the possibility that PKC genes may be
targeted for the action of heparin was investigated in cultured
HEC. Here, we demonstrate that heparin was able to inhibit
both the serum- and phorbol 12-myristate 13-acetate (PMA)-
stimulated isoenzyme gene expression and hypothesize that
the polyelectrolyte may a¡ect the PKC-mediated autoregula-
tion of PKC genes.
2. Materials and methods
2.1. Cell culture and exposure
HEC were isolated from human umbilical cords and cultured as
previously described [22]. Brie£y, HEC were detached from the inte-
rior of the umbilical vein of a 30 cm segment cord by treatment for 10
min at 37‡C with 0.05% (w/v) collagenase type II from Clostridium
hystolyticum (Gibco BRL, Paisley, UK) in medium M199 (Gibco
BRL, Paisley, UK) containing 100 U/ml of penicillin G sodium salt
and 100 Wg/ml streptomycin sulfate (Sigma Chemical, St. Louis, MO,
USA). HEC were harvested at 1000Ug for 10 min and ¢nally resus-
pended in 5 ml medium M199 supplemented with 10% (v/v) foetal calf
serum (FCS), 10% (v/v) newborn-calf serum (Gibco BRL, Paisley,
UK), 2 mM glutamine and antibiotics. Cells were then plated in 25
cm2 tissue culture £asks (Falcon, Oxnard, CA, USA) and cultured in
an atmosphere of 5% CO2/95% air. When con£uent, HEC were sub-
cultured at a split ratio of 1:2 by a brief treatment with 0.1% trypsin
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plus 0.02% EDTA in phosphate bu¡ered saline (PBS) (120 mM NaCl,
2.5 mM KCl, 8.5 mM NaH2PO4, 1.5 mM KH2PO4), pH 7.3. Cul-
tured cells were identi¢ed as endothelial by their typical cobblestone
appearance and production of Von Willebrand factor as measured by
an enzyme-linked immunosorbent assay [23]. Subcon£uent cells were
synchronized following a 48 h incubation in serum-free medium M199
containing 0.2% (w/v) bovine serum albumin (BSA) (Sigma Chemical,
St. Louis, MO, USA). Synchronized subcon£uent HEC grown in 25
cm2 culture £asks were stimulated to growth for the indicated time
intervals in the presence of medium M199 containing 10% FCS or in a
serum-free medium containing 100 nM PMA (Sigma Chemical, St.
Louis, MO, USA). Under the same experimental conditions,
synchronized subcon£uent HEC also received di¡erent concentrations
of heparin as described in the ¢gure legend. PKC down-regulation
was accomplished by exposing HEC to serum-free medium containing
1 WM PMA during the last 24 h of cell synchronization [24]. The PKC
inhibitors chelerythrine or calphostin C (Alexis corporation, San Die-
go, CA, USA) were added at a concentration of 2.5 WM and 1 WM,
respectively, during the last 4 h of cell synchronization.
2.2. RNA extraction and reverse transcriptase polymerase chain
reaction (RT-PCR) assessment of mRNAs
Total RNA was extracted at the indicated time points, according to
the procedure described by Chomczynski and Sacchi [25]. The PKC
mRNA expression was evaluated by RT-PCR [26]. Total RNA (1 Wg)
from synchronized subcon£uent HEC treated as indicated, was re-
verse-transcribed for 45 min at 37‡C. The reaction was performed
in a solution of 25 Wl, containing 50 mM Tris-HCl pH 8.3, 75 mM
KCl, 3 mM MgCl2, 10 mM dithiothreitol (DTT), 0.2 mM of each
dNTP, 0.1 Wg of oligo dT, 200 U of M-MLV reverse transcriptase
(Gibco BRL, Paisley, UK). The reaction mixture was then heated at
95‡C for 5 min to inactivate the enzyme. PCR ampli¢cation was
performed in 25 Wl of a reaction mixture containing 5 Wl of the reverse
transcribed cDNA, 20 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 2.5 U of Taq polymerase (Gibco BRL, Paisley, UK), 0.2 mM
of each dNTP and 50 pmol of each sense and antisense primers that
were previously dissolved in TE solutions (Tris 10 mM pH 8.0,
EDTA, 1 mM pH 8.0). The number of ampli¢cation cycles was de-
termined experimentally for each primer pair by establishing the point
at which exponential accumulation plateaus. Aliquots of the PCR
reactions, including 0.5 WCi of [K-32P]dCTP (3000 Ci/mmol) were
taken after 10, 15, 20, 25, 30, 35 and 40 cycles. Then, [K-32P]dCTP-
labelled PCR products were electrophoresed on 2% agarose gels. Ethi-
dium bromide-stained bands were excized under UV light and the
radioactivity incorporated into PCR products was determined by L-
scintillation counting. Under these experimental conditions, and using
30 PCR cycles, [K-32P]dCTP-labelled time course experiments revealed
that the products of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), PKC-K and -N ampli¢cation were all within the linear
phase of the reaction. Indeed, similar conditions are previously re-
ported for a semiquantitative analysis of gene expression [27,28].
The position of PCR fragments was evaluated by comparison with
a DNA molecular weight marker (Gibco BRL, Paisley, UK).
GAPDH mRNA was used for each sample as an internal control
for the mRNA integrity and equal loading. The levels of radioactivity
incorporated into PKC-N and -K products were normalized by com-
parison with the levels of radioactivity incorporated into the GAPDH
product from the same sample. Speci¢c primers directed against hu-
man sequences for PKC-K, -N and GAPDH were previously described
[29]. Their sequences, PCR reaction conditions and the size of gener-
ated fragments are shown in Table 1.
2.3. Statistical analysis
The statistical analysis of the data was performed by using the
unpaired Student’s t test, assuming a P value less than 0.05 as the
limit of signi¢cance. Data are expressed as mean þ S.E.
3. Results
To assess that PCR reactions for GAPDH, PKC-K and -N
were in the linear phase, 1 Wg RNA sample from synchronized
subcon£uent HEC, stimulated with serum for 1, 2, 4, 6, 12
and 24 h was reverse-transcribed. 5 Wl of the resulting cDNA
was ampli¢ed for 10, 20, 25, 30, 35 and 40 cycles. Fig. 1
reports the expression of the PKC-N and -K genes following
a serum treatment of 1 or 6 h, respectively, corresponding to
Table 1
Gene Deoxyoligonucleotide sequences Product base pair Ampli¢cation condition
PKC-K Forward, 5P-CGACTCTCTGTAGAAATCTGG-3P 443 95‡C for 30 s
Reverse, 5P-CACCATGGTGCACTCCACGTC-3P 58‡C for 30 s
72‡C for 1 min
PKC-N Forward, 5P-AAAGGCAGCTTCGGGAAGGT-3P 260 95‡C for 30 s
Reverse, 3P-TGGATGTGGTACATCAGGTC 58‡C for 30 s
72‡C for 1 min
GAPDH Forward, 5P-CCACCCATGGCAAATTCCATGGCA-3P 598 95‡C for 30 s
Reverse, 5P-TCTAGACGGCAGGTCAGGTCCACC-3P 58‡C for 30 s
72‡C for 1 min
Fig. 1. Upper, representative ethidium bromide-stained gel of the re-
action products obtained using 5 Wl of the reverse transcriptase
(RT) products after the indicated cycles of ampli¢cation for
GAPDH, PKC-K and PKC-N. Lower, graph demonstrating the line-
arity of reaction products obtained using 5 Wl of RT product after
the indicated cycles of [K-32P]dCTP-labelled PCR ampli¢cation for
GAPDH, PKC-K and PKC. Synchronized subcon£uent HEC were
stimulated with 10% FCS for 1, 2, 4, 6, 12 and 24 h. Then, the
total RNA was extracted and processed for RT-PCR analysis.
b GAPDH, HEC were stimulated with 10% FCS for 6 h. PKC-N,
HEC were stimulated with 10% FCS for 1 h. PKC-K, HEC were
stimulated with 10% FCS for 6 h. Data are the mean þ S.E. of four
di¡erent experiments. CPM, counts per minute.
FEBS 21905 19-4-99
G. Pintus et al./FEBS Letters 449 (1999) 135^140136
the maximal e¡ect of serum on the expression of each PKC
gene. After the demonstration of linear PCR conditions at 30
cycles (Fig. 1), we investigated the expression of PKC-K and
PKC-N mRNA in synchronized subcon£uent HEC that were
cultured with 10% FCS, in the absence or presence of heparin.
Serum elicited a time-dependent increase in PKC-K and -N
mRNAs (Fig. 2A, B). In the presence of serum, the PKC-N
gene expression reached a maximum at 1 h, thereafter pro-
gressively declined and returned to the control value at 12 h
(Fig. 2A). Serum-induced overexpression of PKC-K mRNA
was already evident at 2 h, but peaked after 6 h of treatment
(Fig. 2B). The addition of heparin (200 Wg/ml) to the incuba-
tion medium signi¢cantly, although not completely, inhibited
the serum-stimulated PKC-N and -K gene expression (Fig. 2C,
D). We have previously shown that heparin failed to abolish
completely the serum-stimulated DNA synthesis in HEC and
Fig. 3. A, B: time course of the e¡ect of 100 nM PMA on PKC-N
(A) and -K (B) mRNA expression in HEC. At the indicated time
points, total RNA was extracted and processed for RT-PCR analy-
sis. The upper part of each panel shows ethidium bromide-stained
gels of the reaction products obtained using 5 Wl of the RT prod-
ucts after 30 cycles of PCR ampli¢cation for GAPDH, PKC-N (A)
and PKC-K (B). The lower parts of A and B report the expression
of PKC-N (A) and PKC-K (B) mRNA, detected by [K-32P]dCTP-
PCR (30 cycles) using 5 Wl of RT product. Data represent the
mean þ S.E. of four di¡erent experiments. *, signi¢cantly di¡erent
from time 0. C, E: dose-response of the PMA e¡ect on the PKC-N
(C) and -K (E) mRNA expression in HEC. Cells, cultured in a se-
rum-free medium, were stimulated with the indicated concentrations
of PMA for 1 h (C) or 6 h (E). Total RNA was extracted and proc-
essed for RT-PCR analysis. Expression of PKC-N (C) and -K (D)
mRNA was detected by [K-32P]dCTP-PCR (30 cycles), using 5 Wl of
RT product. Data represent the mean þ S.E. of four di¡erent experi-
ments. *, signi¢cantly di¡erent from 0 nM PMA. D, F: inhibition
of the PMA-induced PKC-N (D) or -K (F) mRNA expression by
chelerythrine (CHE) (2.5 WM), calphostin C (CAL) (1 WM) or PKC
down-regulation (DR). 4K-phorbol, HEC were stimulated for 1 h
(D) or 6 h (F) with 100 nM of the inactive phorbol ester;
DR+PMA, down-regulated HEC were stimulated for 1 h (D) or 6 h
(F) with 100 nM PMA; CHE+PMA, chelerythrine-treated cells
were stimulated for 1 h (D) or 6 h (F) with 100 nM PMA;
CAL+PMA, calphostin C-treated cells were stimulated for 1 h (D)
or 6 h (F) with 100 nM PMA. Data represent the mean þ S.E. of
four di¡erent experiments. 3, signi¢cantly di¡erent from 100 nM
PMA. In A^E, results were normalized to the GAPDH mRNA ex-
pression detected in each sample and expressed as a ratio to
GAPDH.
Fig. 2. A, B: time course of the e¡ect of 10% FCS on PKC-N (A)
and PKC-K (B) mRNA expression in HEC. At the indicated time
points, total RNA was extracted and processed for RT-PCR analy-
sis. The upper part of each panel shows ethidium bromide-stained
gels of the reaction products obtained using 5 Wl of the RT prod-
ucts after 30 cycles of PCR ampli¢cation for GAPDH, PKC-N (A)
and PKC-K (B). The lower parts of A and B show serum-induced
expression of PKC-N (A) or PKC-K (B) mRNA detected by
[K-32P]dCTP-PCR (30 cycles) using 5 Wl of RT product. Data repre-
sent the mean þ S.E. of four di¡erent experiments. *, signi¢cantly
di¡erent from time 0. C, D: The e¡ect of heparin (HEP) on the se-
rum-mediated PKC-N (C) and -K (D) mRNA expression in HEC.
Cells were stimulated with 10% FCS for 1 h (C) or 6 h (D), in the
absence (CTRL) or presence of 200 Wg/ml heparin. The upper part
of each panel reports ethidium bromide-stained gels of the reaction
products obtained using 5 Wl of the RT products after 30 cycles of
PCR ampli¢cation for GAPDH, PKC-N (C) and PKC-K (D). The
lower parts of C and D show the expression of PKC-N (C) or PKC-
K (D) mRNA detected by [K-32P]dCTP-PCR (30 cycles) using 5 Wl
of RT product. Data represent the mean þ S.E. of six di¡erent ex-
periments. *, signi¢cantly di¡erent from CTRL. In A^D, individual
results were normalized to GAPDH mRNA detected in each sample
and expressed as a ratio to GAPDH.
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that the e¡ect of the polyelectrolyte occurred by the inhibition
of a serum-activated PKC-dependent pathway [21]. Here, we
investigated whether such a signalling mechanism may also be
involved in the induction of PKC genes. Fig. 3 (A, B) shows
that in serum-free cells, 100 nM PMA increased the PKC-K
and -N gene expression with a similar time course as that
observed in the presence of serum. However, the peak increase
in PKC-K or -N mRNA was higher in serum-stimulated than
in PMA-treated cells (Fig. 4A, C) and no additivity was ob-
served between the e¡ects produced by FCS and PMA upon
PKC mRNA expression (Fig. 4A, C). The e¡ect elicited by
PMA on PKC-K and -N mRNA levels was dose-dependent
(Fig. 3C, E) and was not observed in the presence of chelery-
thrine or calphostin C, two selective PKC inhibitors [30,31]
(Fig. 3D, F). PMA failed to a¡ect the PKC gene expression in
PKC down-regulated cells (Fig. 3D, F). The same ¢gure
shows that no increase in PKC mRNAs could be observed
in cells that were exposed to the biochemically inactive phor-
bol 4K-phorbol 12, 13-didecanoate (4K-phorbol). On the other
hand, both chelerythrine and PKC down-regulation elicited
no more than 50% reduction of PKC-K and -N mRNA in
serum-treated cells (Fig. 4A, C). The addition of heparin
(200 Wg/ml) to chelerythrine-treated or PKC down-regulated
cells failed to produce any additive inhibition in the residual
e¡ect of FCS (Fig. 4A, C). On the contrary, heparin dose-
dependently suppressed the stimulatory e¡ect of PMA on
both the PKC-K and -N gene expression (Fig. 4B, D).
4. Discussion
Heparin and heparan sulfate are complex glycosaminogly-
cans that exert antiproliferative e¡ects in di¡erent cell types
[32,33,14^16]. Consonant with growth inhibition, heparin in-
hibits the expression of the early proto-oncogenes c-fos and c-
myc by acting selectively on a PKC-dependent pathway [18^
20]. The inhibition of this signalling pathway was also found
to be the mechanism by which heparin down-regulated the
ODC gene expression and cell proliferation in EC [21]. It is
increasingly becoming evident that PKC isoenzyme gene ex-
pression, besides enzyme activity, may elicit complex cellular
responses. Overexpression of PKC-K promoted the prolifera-
tion of several cell types, including ¢broblasts and endothelial
cells [34^36], while inhibiting the proliferation of rat smooth
muscle cells and F9 teratocarcinoma cell lines [37,38]. Stably
transfected NIH 3T3 ¢broblasts, overexpressing human PKC-
K under the control of the interferon type I inducible murine
Mx promoter, exhibited a 10-fold increase in the transcription
of PKC-K mRNA along with an increase in the growth rate
and early gene expression [39]. Moreover, growth conditions
a¡ected the expression of PKC genes. Serum starvation in
KT3-1 cells was found to remarkably modify the time course
of both phorbol ester- and gonadotropin-releasing hormone
A-induced PKC-N mRNA, as compared to the induction ob-
served in non-starved cells [40].
Here, we assessed whether serum and/or PMA may a¡ect
Fig. 4. A, C: inhibition of FCS-stimulated PKC-N (A) and -K (C) mRNA expression by chelerythrine (CHE) (2.5 WM) or PKC down-regulation
(DR) in HEC. Expression of PKC-N (A) and -K (C) mRNA was detected by [K-32P]dCTP-PCR (30 cycles) using 5 Wl of RT product. UN-
TREATED, untreated cells; FCS, HEC stimulated for 1 h (A) or 6 h (C) with 10% FCS; FCS+HEP, HEC stimulated for 1 h (A) or 6 h (C)
with 10% FCS plus 200 Wg/ml HEP; DR+FCS, down-regulated HEC stimulated for 1 h (A) or 6 h (C) with 10% FCS; CHE+FCS, cheleryth-
rine-treated HEC stimulated for 1 h (A) or 6 h (C) with 10% FCS; DR+FCS+HEP, down-regulated HEC stimulated for 1 h (A) or 6 h (C)
with 10% FCS plus 200 Wg/ml HEP; CHE+FCS+HEP, chelerythrine-treated HEC stimulated for 1 h (A) or 6 h (C) with 10% FCS plus 200
Wg/ml HEP; FCS+PMA, HEC stimulated for 1 h (A) or 6 h (C) with 10% FCS plus 100 nM PMA; PMA, HEC stimulated for 1 h (A) or 6 h
(C) with 100 nM PMA; PMA+HEP, HEC stimulated for 1 h (A) or 6 h (C) with 100 nM PMA plus 200 Wg/ml HEP. Data represent the
mean þ S.E. of four di¡erent experiments. *, signi¢cantly di¡erent from untreated. #, signi¢cantly di¡erent from FCS. 3, signi¢cantly di¡erent
from PMA. B, D: dose-response e¡ect of the indicated concentrations of heparin on the PKC-N (B) and -K (D) mRNA expression induced by
100 nM PMA in HEC. Cells, cultured in serum-free medium, were stimulated for 1 h (B) or 6 h (D) with 100 nM PMA, in the absence (0) or
presence of the indicated concentrations of HEP. Expression of PKC-N (B) and -K (D) mRNA was detected by [K-32P]dCTP-PCR (30 cycles)
using 5 Wl of RT product. UNTREATED, untreated cells; FCS, HEC stimulated for 1 h (B) or 6 h (D) with 10% FCS; FCS+HEP, HEC
stimulated for 1 h (B) or 6 h (D) with 10% FCS plus 200 Wg/ml HEP. Data represent the mean þ S.E.M. of four di¡erent experiments. *, signif-
icantly di¡erent from UNTREATED. #, signi¢cantly di¡erent from FCS. 3, signi¢cantly di¡erent from 0 Wg/ml of heparin. Results were nor-
malized to GAPDH mRNA detected in each sample and expressed as a ratio to GAPDH.
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the PKC gene expression in HEC and hypothesize that the
growth inhibitory response elicited by heparin in HEC [21]
may be associated with changes in the PKC gene expression.
The current experimental data show that the exposure of
HEC to serum or the treatment with PMA in a serum-free
medium enhanced the expression of both PKC-K and -N
mRNA with a similar time course, suggesting that PKC is
involved in serum stimulation of the PKC gene expression.
In fact, the treatment with serum in the presence of PMA
did not produce additive e¡ects on PKC mRNA levels, fur-
ther supporting the role of PKC in mediating the serum e¡ect
on the PKC gene expression. The possibility that the observed
increase in the serum-induced expression of PKC genes may
be mediated by the activation of a PKC-dependent pathway is
suggested by the ¢nding that chelerythrine and calphostin C,
as well as PKC down-regulation, signi¢cantly, although not
completely, reduced the stimulatory e¡ect of serum. Failure of
PKC inhibition or depletion of abolishing completely the se-
rum-induced expression of PKC-K and -N mRNA indicates
that PKC-independent signalling may also be conceivable.
In this regard, both PKC-dependent and PKC-independent
pathways have been implicated in the ability of serum to
promote early gene expression and proliferative responses in
VSMC [20]. Consistent with such a possibility are the present
observations showing that the peak increase of PKC mRNA
levels in PMA-treated cells was signi¢cantly lower than that
detected in serum-stimulated cells and that PKC inhibition or
enzyme down-regulation completely inhibited the PMA-in-
duced PKC gene expression in serum-free cells. These ¢ndings
are in agreement with other observations indicating that both
PKC inhibition and down-regulation where able to completely
abolish a stimulatory e¡ect of PKC activation on the PKC-N
[40] and -L gene expression [41]. In addition, in the current
investigation, the speci¢city and PKC-dependence of the stim-
ulatory action of PMA are further supported by the lack of an
e¡ect by the inactive phorbol ester 4K-phorbol.
A number of experimental observations in the present study
suggest the possibility that heparin might exert its inhibitory
action on PKC mRNA levels by inhibiting a PKC-dependent
pathway controlling the PKC gene expression. First, heparin
only partially decreased the stimulatory e¡ect of serum on
PKC-K and -N mRNA, while completely abolishing the
PMA-stimulated PKC gene expression. Secondly, heparin
failed to further decrease PKC-K and -N mRNA levels in
chelerythrine-treated serum-supplemented cells. Third, no sig-
ni¢cant e¡ect of heparin on the PKC gene expression could be
observed in serum-exposed cells following PKC down-regula-
tion. These ¢ndings support the hypothesis that (i) the poly-
electrolyte may have suppressed a serum-activated PKC-de-
pendent pathway controlling the PKC gene expression, being
without an e¡ect on a residual serum-stimulated PKC-unre-
lated gene expression, (ii) PKC inhibition or down-regulation,
as well as the treatment in the presence of heparin, might have
inhibited the PKC gene expression by following the same
signal transduction pathway.
Evidence for a cross-talk between PKC activation and the
induction of selected PKC genes has been recently provided.
In particular, PKC-K overexpression in Baf3 and 32D cells
has been found to elevate the PKC-N mRNA expression by
acting at the transcriptional level. Such an e¡ect was mim-
icked by phorbol ester and could be abolished by the PKC
inhibitor GF109203X, indicating the requirement for PKC
activity [42]. The present observation that the inhibitory e¡ect
of heparin on the PKC gene expression required an activated
PKC-dependent pathway indicates that the polyelectrolyte
may abolish some form of cross-regulation between the
PKC activity and PKC gene expression. Whether the inter-
ruption of this regulatory circuit may a¡ect the distribution of
PKC isoenzymes in di¡erent subcellular compartments re-
mains to be elucidated.
Similarly, the possible implications of the present study re-
main to be established. However, it is now evident that the
endothelial cell plays a crucial role in the angiogenesis [43]
and that it might a¡ect the growth and di¡erentiation of
neighboring cells [44]. The endothelial cell is also the target
cell for tumor neovascularization [45], a process that closely
associates with tumor growth and metastasis [46]. In this re-
gard, heparin, a molecule tightly related to the heparan sulfate
component of the extracellular matrix, exerts remarkable ef-
fects on the angiogenesis [17] and has been shown to a¡ect the
cell proliferation under normal [33,14^16] or pathological con-
ditions [47,48,32]. Interestingly, heparin has been found to
inhibit both the increase of the PKC activity and myointimal
proliferation elicited by balloon injury in rat carotid artery in
vivo [49]. Therefore, heparin-mediated inhibition of PKC gene
expression might also represent a vascular remodelling mech-
anism.
To our knowledge, this is the ¢rst report demonstrating
that heparin a¡ects the PKC gene expression, through the
inhibition of a PKC-related mechanism. The present ¢nding
supports the hypothesis that the interruption mediated by
heparin of a PKC-dependent control on PKC gene patterning
may be a part of the complex machinery by which glycosa-
minoglycans modulate cellular responses under normal or
pathological conditions.
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